https://regulatorynews.com/fda-estar-mandatory-ide-applications Regulatory News en 2026-10-30T05:55:52-04:00 FDA Drafts a Mandatory eSTAR Path for Device Trials https://regulatorynews.com/fda-revises-drug-delivery-device-guidance Regulatory News en 2026-10-30T05:55:52-04:00 FDA Revises Its Drug-Delivery Device Test Guidance https://regulatorynews.com/hhs-peptide-compounding-enforcement-discretion Regulatory News en 2026-10-30T05:55:52-04:00 HHS Clears Compounding of Six Unapproved Peptides https://regulatorynews.com/yuviwel-achondroplasia-physicians Regulatory News en 2026-10-29T11:05:58-04:00 CHMP Backs Second Achondroplasia Drug, Dosed Weekly https://regulatorynews.com/medicovestor-mc001-fast-track-designation Regulatory News en 2026-10-29T09:54:06-04:00 Medicovestor Earns FDA Fast Track for Pancreatic ADC https://regulatorynews.com/xbrane-lucamzi-fda-approval Regulatory News en 2026-10-29T09:54:06-04:00 Xbrane Wins FDA Nod for Lucamzi Eye Biosimilar https://regulatorynews.com/baxter-round-lake-warning-letter Regulatory News en 2026-10-29T05:58:49-04:00 FDA Warns Baxter Over Repeat Sterile-Plant Failures https://regulatorynews.com/pfizer-talzenna-xtandi-mhspc-approval Regulatory News en 2026-10-29T05:58:49-04:00 FDA Expands Talzenna-Xtandi to Earlier Prostate Cancer https://regulatorynews.com/awiqli-pediatric-icodec-physicians Regulatory News en 2026-10-28T10:48:52-04:00 FDA Extends Once-Weekly Awiqli to Pediatric T2D https://regulatorynews.com/zydus-climara-pro-generic-physicians Regulatory News en 2026-10-28T10:48:52-04:00 FDA Approves First Generic Combined Menopause Patch